MedPath

Optimizing osteoporosis treatment outcomes: shared-decision making and adherence support program

Conditions
Osteoporosis
Registration Number
NL-OMON22858
Lead Sponsor
Maastricht University Medical Centre Maastricht (Netherlands). Viecuri Medical Centre, Venlo (Netherlands).
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
210
Inclusion Criteria

I) Recent fracture

II) Diagnosed with Osteoporosis (confirmed with dual-energy x-ray absorptiometry (DXA))

Exclusion Criteria

I) Beeing treated for malignancies.

II) Incapable to comprehend the treatment and the study.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
I) The effect of the MCAI on medication persistence.<br><br /><br /><br>II) The estimated lifetime cost-effectiveness of the MCAI compared to usual care for healthcare and societal perspective. <br>
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes include: decision quality, medication initiation, alternative measures of adherence, health status (fracture events and mortality), quality of life and societal costs.
© Copyright 2025. All Rights Reserved by MedPath